Envoy Medical (COCH) Competitors

Envoy Medical logo
$6.70 -0.03 (-0.45%)
Closing price 11/19/2026 04:00 PM Eastern
Extended Trading
$6.64 -0.06 (-0.96%)
As of 11/19/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

COCH vs. VANI, ELMD, KRMD, INGN, and TLSI

Should you buy Envoy Medical stock or one of its competitors? Envoy Medical's main competitors and comparable companies include Vivani Medical (VANI), Electromed (ELMD), KORU Medical Systems (KRMD), Inogen (INGN), and TriSalus Life Sciences (TLSI). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does Envoy Medical compare to Vivani Medical?

Vivani Medical (NASDAQ:VANI) and Envoy Medical (NASDAQ:COCH) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, media sentiment, earnings, analyst recommendations, risk, profitability and valuation.

Vivani Medical currently has a consensus target price of $3.75, indicating a potential upside of 244.04%. Envoy Medical has a consensus target price of $21.00, indicating a potential upside of 213.43%. Given Vivani Medical's stronger consensus rating and higher possible upside, equities research analysts plainly believe Vivani Medical is more favorable than Envoy Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vivani Medical
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Envoy Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

6.8% of Vivani Medical shares are owned by institutional investors. Comparatively, 8.6% of Envoy Medical shares are owned by institutional investors. 53.3% of Vivani Medical shares are owned by insiders. Comparatively, 7.2% of Envoy Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Vivani Medical has a net margin of 0.00% compared to Envoy Medical's net margin of -9,026.41%. Envoy Medical's return on equity of 0.00% beat Vivani Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Vivani MedicalN/A -161.39% -68.14%
Envoy Medical -9,026.41%N/A -112.19%

In the previous week, Vivani Medical had 12 more articles in the media than Envoy Medical. MarketBeat recorded 13 mentions for Vivani Medical and 1 mentions for Envoy Medical. Vivani Medical's average media sentiment score of 0.83 beat Envoy Medical's score of 0.46 indicating that Vivani Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Vivani Medical
5 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Envoy Medical
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Vivani Medical has a beta of 2.51, meaning that its share price is 151% more volatile than the broader market. Comparatively, Envoy Medical has a beta of 2.03, meaning that its share price is 103% more volatile than the broader market.

Envoy Medical has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vivani MedicalN/AN/A-$26.61M-$0.32N/A
Envoy Medical$231K224.64-$23.76M-$4.60N/A

Summary

Vivani Medical beats Envoy Medical on 9 of the 14 factors compared between the two stocks.

How does Envoy Medical compare to Electromed?

Electromed (NYSE:ELMD) and Envoy Medical (NASDAQ:COCH) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, risk, valuation, earnings, institutional ownership, analyst recommendations, profitability and media sentiment.

Electromed has a beta of 0.43, meaning that its stock price is 57% less volatile than the broader market. Comparatively, Envoy Medical has a beta of 2.03, meaning that its stock price is 103% more volatile than the broader market.

Electromed has higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Electromed$75.57M2.52$5.15M$1.3816.86
Envoy Medical$231K224.64-$23.76M-$4.60N/A

40.8% of Electromed shares are held by institutional investors. Comparatively, 8.6% of Envoy Medical shares are held by institutional investors. 11.0% of Electromed shares are held by company insiders. Comparatively, 7.2% of Envoy Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Electromed had 1 more articles in the media than Envoy Medical. MarketBeat recorded 2 mentions for Electromed and 1 mentions for Envoy Medical. Electromed's average media sentiment score of 0.76 beat Envoy Medical's score of 0.46 indicating that Electromed is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Electromed
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Envoy Medical
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Electromed has a net margin of 11.34% compared to Envoy Medical's net margin of -9,026.41%. Electromed's return on equity of 15.71% beat Envoy Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Electromed11.34% 15.71% 13.37%
Envoy Medical -9,026.41%N/A -112.19%

Electromed currently has a consensus target price of $43.75, suggesting a potential upside of 88.09%. Envoy Medical has a consensus target price of $21.00, suggesting a potential upside of 213.43%. Given Envoy Medical's higher possible upside, analysts clearly believe Envoy Medical is more favorable than Electromed.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Electromed
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75
Envoy Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

Summary

Electromed beats Envoy Medical on 13 of the 16 factors compared between the two stocks.

How does Envoy Medical compare to KORU Medical Systems?

KORU Medical Systems (NASDAQ:KRMD) and Envoy Medical (NASDAQ:COCH) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, risk, dividends and valuation.

KORU Medical Systems currently has a consensus price target of $6.50, indicating a potential upside of 88.95%. Envoy Medical has a consensus price target of $21.00, indicating a potential upside of 213.43%. Given Envoy Medical's higher probable upside, analysts clearly believe Envoy Medical is more favorable than KORU Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
KORU Medical Systems
1 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.43
Envoy Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

KORU Medical Systems has higher revenue and earnings than Envoy Medical. KORU Medical Systems is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
KORU Medical Systems$41.13M3.63-$2.64M-$0.02N/A
Envoy Medical$231K224.64-$23.76M-$4.60N/A

58.6% of KORU Medical Systems shares are held by institutional investors. Comparatively, 8.6% of Envoy Medical shares are held by institutional investors. 18.5% of KORU Medical Systems shares are held by company insiders. Comparatively, 7.2% of Envoy Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, KORU Medical Systems had 1 more articles in the media than Envoy Medical. MarketBeat recorded 2 mentions for KORU Medical Systems and 1 mentions for Envoy Medical. Envoy Medical's average media sentiment score of 0.46 beat KORU Medical Systems' score of 0.20 indicating that Envoy Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
KORU Medical Systems
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Envoy Medical
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

KORU Medical Systems has a net margin of -1.78% compared to Envoy Medical's net margin of -9,026.41%. Envoy Medical's return on equity of 0.00% beat KORU Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
KORU Medical Systems-1.78% -4.62% -2.90%
Envoy Medical -9,026.41%N/A -112.19%

KORU Medical Systems has a beta of 0.47, suggesting that its stock price is 53% less volatile than the broader market. Comparatively, Envoy Medical has a beta of 2.03, suggesting that its stock price is 103% more volatile than the broader market.

Summary

KORU Medical Systems beats Envoy Medical on 10 of the 15 factors compared between the two stocks.

How does Envoy Medical compare to Inogen?

Envoy Medical (NASDAQ:COCH) and Inogen (NASDAQ:INGN) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, dividends, earnings, analyst recommendations and valuation.

Envoy Medical has a beta of 2.03, meaning that its share price is 103% more volatile than the broader market. Comparatively, Inogen has a beta of 1.51, meaning that its share price is 51% more volatile than the broader market.

Envoy Medical currently has a consensus target price of $21.00, indicating a potential upside of 213.43%. Given Envoy Medical's higher possible upside, equities research analysts clearly believe Envoy Medical is more favorable than Inogen.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envoy Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Inogen
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.50

In the previous week, Inogen had 1 more articles in the media than Envoy Medical. MarketBeat recorded 2 mentions for Inogen and 1 mentions for Envoy Medical. Envoy Medical's average media sentiment score of 0.46 beat Inogen's score of -0.35 indicating that Envoy Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Envoy Medical
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Inogen
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Inogen has higher revenue and earnings than Envoy Medical. Inogen is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envoy Medical$231K224.64-$23.76M-$4.60N/A
Inogen$348.67M0.40-$22.75M-$1.31N/A

8.6% of Envoy Medical shares are owned by institutional investors. Comparatively, 89.9% of Inogen shares are owned by institutional investors. 7.2% of Envoy Medical shares are owned by insiders. Comparatively, 2.5% of Inogen shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Inogen has a net margin of -10.46% compared to Envoy Medical's net margin of -9,026.41%. Envoy Medical's return on equity of 0.00% beat Inogen's return on equity.

Company Net Margins Return on Equity Return on Assets
Envoy Medical-9,026.41% N/A -112.19%
Inogen -10.46%-19.29%-12.02%

Summary

Inogen beats Envoy Medical on 9 of the 16 factors compared between the two stocks.

How does Envoy Medical compare to TriSalus Life Sciences?

Envoy Medical (NASDAQ:COCH) and TriSalus Life Sciences (NASDAQ:TLSI) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, dividends, analyst recommendations, institutional ownership and earnings.

In the previous week, TriSalus Life Sciences had 19 more articles in the media than Envoy Medical. MarketBeat recorded 20 mentions for TriSalus Life Sciences and 1 mentions for Envoy Medical. TriSalus Life Sciences' average media sentiment score of 0.48 beat Envoy Medical's score of 0.46 indicating that TriSalus Life Sciences is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Envoy Medical
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
TriSalus Life Sciences
5 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

TriSalus Life Sciences has a net margin of -56.60% compared to Envoy Medical's net margin of -9,026.41%.

Company Net Margins Return on Equity Return on Assets
Envoy Medical-9,026.41% N/A -112.19%
TriSalus Life Sciences -56.60%N/A -55.00%

Envoy Medical presently has a consensus target price of $21.00, suggesting a potential upside of 213.43%. TriSalus Life Sciences has a consensus target price of $9.20, suggesting a potential upside of 323.96%. Given TriSalus Life Sciences' stronger consensus rating and higher probable upside, analysts plainly believe TriSalus Life Sciences is more favorable than Envoy Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envoy Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
TriSalus Life Sciences
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

Envoy Medical has higher earnings, but lower revenue than TriSalus Life Sciences. TriSalus Life Sciences is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envoy Medical$231K224.64-$23.76M-$4.60N/A
TriSalus Life Sciences$45.15M2.96-$39.23M-$0.49N/A

Envoy Medical has a beta of 2.03, suggesting that its stock price is 103% more volatile than the broader market. Comparatively, TriSalus Life Sciences has a beta of 0.5, suggesting that its stock price is 50% less volatile than the broader market.

8.6% of Envoy Medical shares are held by institutional investors. Comparatively, 2.6% of TriSalus Life Sciences shares are held by institutional investors. 7.2% of Envoy Medical shares are held by company insiders. Comparatively, 16.3% of TriSalus Life Sciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

TriSalus Life Sciences beats Envoy Medical on 10 of the 14 factors compared between the two stocks.

Get Envoy Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for COCH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COCH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COCH vs. The Competition

MetricEnvoy MedicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$52.12M$5.92B$7.57B$11.65B
Dividend YieldN/A1.69%2.48%4.66%
P/E Ratio-1.4639.2133.2128.34
Price / Sales224.645.308.285.45
Price / CashN/A23.4220.7221.66
Price / Book-33.504.154.423.65
Net Income-$23.76M$143.14M$3.51B$394.00M
7 Day Performance-0.59%-4.70%-5.53%-5.64%
1 Month Performance5.59%-6.69%-8.71%-9.48%
1 Year Performance-3.90%-1.05%-1.44%-6.81%

Envoy Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COCH
Envoy Medical
3.0623 of 5 stars
$6.70
-0.4%
$21.00
+213.4%
-5.7%$52.12M$231KN/A47
VANI
Vivani Medical
3.8961 of 5 stars
$1.12
-2.6%
$3.75
+234.8%
-20.4%$101.02MN/AN/A36
ELMD
Electromed
2.3541 of 5 stars
$24.96
-8.2%
$43.75
+75.3%
-7.7%$206.84M$73.78M33.28197
KRMD
KORU Medical Systems
3.7479 of 5 stars
$3.89
+23.1%
$6.50
+67.1%
-20.9%$178.68M$45.11MN/A73
INGN
Inogen
0.8395 of 5 stars
$5.75
-4.2%
N/A-19.0%$152.61M$348.67MN/A753

Related Companies and Tools


This page (NASDAQ:COCH) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners